Showing results (61-70 of 150) with videos related to

Sort By:
Pageof 15
Schizophrenia Research|August 14, 2021
Association between tobacco use and symptomatology in individuals at ultra-high risk to develop a psychosis: A longitudinal studyHeleen S van der Heijden, Frederike Schirmbeck, Philip McGuire, et al.
European Urology Oncology|April 29, 2025
Novel Molecular Biomarkers to Guide Treatment Decision-making in Metastatic Urothelial Cancer-A Patient Cohort AnalysisDebbie G J Robbrecht, Youssra Salhi, John W M Martens, et al.
BMC Cancer|July 25, 2024
Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 studyAndrea Necchi, Michiel S Van der Heijden, Dmytro Trukhin, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2026
Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patternsD Quatannens, Y Verhoeven, S van der Heijden, et al.
International Journal of Cancer|May 23, 2022
Survival after neoadjuvant/induction combination immunotherapy vs combination platinum-based chemotherapy for locally advanced (Stage III) urothelial cancerSarah M H Einerhand, Nick van Dijk, Jeroen van Dorp, et al.
Cancer Discovery|August 21, 2020
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint BlockadeQu Zhang, Jia Luo, Song Wu, et al.
Nature Communications|March 22, 2024
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitorsAlberto Gil-Jimenez, Nick van Dijk, Joris L Vos, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2025
Model-informed development of a cost-saving dosing regimen for enfortumab vedotinCatharina Jp Op 't Hoog, Amy Rieborn, Dirk Jan Ar Moes, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2016
Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based studyTom J N Hermans, Elisabeth E Fransen van de Putte, Simon Horenblas, et al.
Frontiers in Oncology|September 15, 2023
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trialC F Stockem, J J J Mellema, B W G van Rhijn, et al.
Pageof 15